Filing Details
- Accession Number:
- 0001654954-16-002993
- Form Type:
- 13D Filing
- Publication Date:
- 2016-10-20 14:27:32
- Filed By:
- Defrancesco Catherine Johanna
- Company:
- Riot Platforms Inc. (NASDAQ:RIOT)
- Filing Date:
- 2016-10-20
- SEC Url:
- 13D Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Catherine Johanna DeFrancesco | 362,835 | 0 | 362,835 | 0 | 362,835 | 9.36% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Amendment No. 3
Under the Securities Exchange Act of 1934
Venaxis, Inc.
(Name
of Issuer)
Common stock, no par value
(Title
of Class of Securities)
92262A206
(CUSIP
Number)
Catherine Johanna DeFrancesco
365 Bay St. Suite 840
Toronto, ON M5H 2V1
Canada
Tel. (416) 362-4441
Copies to:
Joe Laxague, Esq.
Laxague Law, Inc.
1 East Liberty, Suite 600
Reno, NV 89501
| Tel.
(775) 234-5221 |
(Name,
Address and Telephone Number of Person Authorized to
Receive
Notices and Communications)
October 18, 2016
(Date
of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of
§§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. ☐
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits.
See Rule.13d-7 for other parties to whom copies are to be
sent.
* The
remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a
prior cover page.
The
information required on the remainder of this cover page shall not
be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see
the Notes).
|
1. Names of Reporting Persons. | |
| | |
|
Catherine Johanna DeFrancesco | |
|
2. Check the Appropriate Box if a Member of a
Group | |
|
(a) [ ] | |
|
(b) [X] | |
| | |
|
3. SEC Use Only | |
|
4. Source of Funds | |
|
WC | |
|
5. Check if Disclosure of Legal Proceedings Is Required
Pursuant to Items 2(d) or 2(e) | |
| ☐ | |
|
6. Citizenship or Place of Organization | |
|
Canada | |
|
Number of Shares
Beneficially
Owned by
Each Reporting
Person With: |
7. Sole Voting Power |
|
362,835(1) | |
| | |
|
8. Shared Voting Power | |
|
0 | |
| | |
|
9. Sole Dispositive Power | |
|
362,835 (1) | |
| | |
|
10. Shared Dispositive Power | |
|
0 | |
| | |
|
11. Aggregate Amount Beneficially Owned by Each
Reporting Person | |
|
362,835 (1) | |
|
12. Check if the Aggregate Amount in Row (11) Excludes
Certain Shares | |
| ☐ | |
|
13. Percent of Class Represented by Amount in Row
(11) | |
|
9.36%(2) | |
|
14. Type of Reporting Person | |
|
IN | |
(1) Includes shares
beneficially owned through the following
entities:
DSB Capital, Ltd., a Turks & Caicos company where Ms.
DeFrancesco serves as the Trustee – 64,759
shares
DeFrancesco Motorsports, Inc., an Ontario corporation where Ms.
DeFrancesco serves as the President – 59,100
shares
Delavalco Holdings, Inc., an Ontario corporation where Ms.
DeFrancesco serves as the President – 81,500
shares
Delavalco Holdings, Inc., an Florida corporation where Ms.
DeFrancesco serves as the President – 85,466
shares
Marcandy Investments Corp., an Ontario corporation where Ms.
DeFrancesco serves as the President – 5,000
shares
Namaste Gorgie, Inc., an Ontario corporation where Ms. DeFrancesco
serves as the President – 67,010 shares
(2) Based on 3,876,961 shares
issued and outstanding as of August 10, 2016, as reported on the
issuer’s Form 10-Q filed August 10, 2016.
Explanatory Notes
This Amendment No. 3 further amends the Schedule 13D filed with the
Securities and Exchange Commission on September 12, 2016 (the
“Original Filing”), the Schedule 13D/A filed September
14, 2016 (“Amendment No. 1), and the Schedule 13D/A filed
September 20, 2016 (Amendment No. 2) respectively, relating to the
common stock, no par value (the “Common Stock”), of
Venaxis, Inc. a Colorado corporation (the “Issuer”).
The address of the principal executive office of the Issuer is 1585
South Perry Street, Castle Rock, Colorado 80104.
The purpose of this Amendment No. 3 is to update the shareholdings
of the Reporting Person to reflect recent additional purchases.
Except as set forth herein, the Original Schedule 13D, Amendment
No. 1, and Amendment No. 2 are unmodified.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
|
Exhibit No. |
Description |
|
1.1 |
Transactions in Shares |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.
October 20, 2016
Date
/s/ Catherine Johanna DeFrancesco
Catherine Johanna DeFrancesco